Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
STOCKHOLM, Sweden, July 10, 2002 (PRIMEZONE) -- Investor's net asset value on June 30, 2002 amounted to SEK 86,639 m. (SEK 113 per share), compared with SEK 118,284 m. on December 31, 2001 (SEK 154...
-
BALTIMORE, July 9, 2002 (PRIMEZONE) -- Law Offices Of Charles J. Piven, P.A. today announced that a securities class action has been commenced on behalf of shareholders who acquired PerkinElmer, Inc....
-
BALA CYNWYD, Pa., July 9, 2002 (PRIMEZONE) -- Shareholders of Interliant, Inc. (Nasdaq:INIT) ("Interliant" or "Company") who desire to serve as a lead plaintiff in a shareholder class action lawsuit...
-
KEENE, N.H., July 9, 2002 (PRIMEZONE) -- Granite State Bankshares, Inc. (Nasdaq:GSBI) today announced net earnings for the three and six months ended June 30, 2002 of $3,721,000 and $7,057,000...
-
NEW YORK, July 8, 2002 (PRIMEZONE) -- Wolf Popper LLP has charged Merrill Lynch & Co., Inc., and its wholly-owned broker-dealer subsidiary and former analyst Henry Blodget, with violations of the...
-
STOCKHOLM, Sweden, July 8, 2002 (PRIMEZONE) -- IBS' quarterly report for the period April-June, 2002, will be published 17 July, at approximately 2 p.m. At 2.30 p.m., an ensuing call-in conference...
-
Overview In September 1995, the Company offered and sold to the public 11,731,613 Warrants at the initial public offering price of $5.00 per Warrant. The exercise price of a Warrant was...
-
LUND, Sweden, July 8, 2002 (PRIMEZONE) -- The Board of Directors of Anoto has resolved that a directed cash issue of 650.000 new shares totalling SEK 14,95 million is offered to Hitachi. The new...
-
STOCKHOLM, Sweden, July 8, 2002 (PRIMEZONE) -- Scandinavian Airlines, Spanair, Braathens Wideroee's and Air Botnia today announced 1. Investor news Improved investor information with yield...
-
HUDDINGE, Sweden, July 8, 2002 (PRIMEZONE) -- Medivir: -- MIV-310 demonstrated powerful antiviral effect on patients with multiresistant HIV; these results, from a phase IIa trial, were ...